Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Demand for water-treatment-related materials is expected to expand, and the Company will focus on expanding sales, particularly of nonwoven fabrics for separation membrane supports. The Company expects earnings to recover as a result of higher sales, based on efforts to strengthen its supply structure through stable operations at the new plant, improve productivity, and optimize selling prices.
Total extraordinary losses: ¥191,244 thousand. Major items comprised impairment losses of ¥88,326 thousand, valuation losses on investment limited partnerships of ¥64,803 thousand, losses from remittance fraud at an overseas subsidiary of ¥35,123 thousand, losses on retirement of fixed assets of ¥2,892 thousand, and losses on sales of fixed assets of ¥98 thousand.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥20,600 million |
| Operating profit | Not disclosed → ¥690 million |
| Ordinary income | Not disclosed → ¥550 million |
| Profit attributable to owners of the parent | Not disclosed → ¥150 million |
| Net income per share | Not disclosed → 15.01 yen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥18,494 million; operating profit: ¥58 million; ordinary loss: ¥95 million; net income attributable to owners of the parent: ¥753 million; net income per share: ¥75.41 |
| Reason for the revision | Demand for water-treatment-related materials is expected to expand, and the Company will focus on expanding sales, particularly of nonwoven fabrics for separation membrane supports. The Company expects earnings to recover as a result of higher sales, based on efforts to strengthen its supply structure through stable operations at the new plant, improve productivity, and optimize selling prices. |
| Details and amount of extraordinary loss | Total extraordinary losses: ¥191,244 thousand. Major items comprised impairment losses of ¥88,326 thousand, valuation losses on investment limited partnerships of ¥64,803 thousand, losses from remittance fraud at an overseas subsidiary of ¥35,123 thousand, losses on retirement of fixed assets of ¥2,892 thousand, and losses on sales of fixed assets of ¥98 thousand. |
| Dividend forecast revision | The dividend forecast for the fiscal year ending March 2027 has not been determined. The Company will promptly disclose the forecast once disclosure becomes possible. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the fiscal year ended March 2026, domestic demand for automotive-related materials remained sluggish, while time was required to respond with alternative products following customers' inventory adjustments and production stoppages at raw-material manufacturers. Sales of water-treatment-related materials increased. On the earnings front, the results were affected by higher depreciation and amortization, raw-material prices, personnel expenses, and transportation costs associated with meeting delivery deadlines. For the fiscal year ending March 2027, the Company expects earnings to recover as a result of higher sales, based on efforts to expand sales in the water-treatment sector, stabilize operations at the new plant, improve productivity, and optimize selling prices.